Stereotaxis Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
STXS$1.14+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
| Three Months Ended March 31, | |||
|---|---|---|---|
| (in thousands) · 2024 · 2023 | |||
| Cash flows from operating activities | |||
| Net loss | $(4,507) | $(5,347) | |
| Adjustments to reconcile net loss to cash used in operating activities: | |||
| Depreciation | 140 | 160 | |
| Non-cash lease expense | 3 | 7 | |
| Stock-based compensation | 2,589 | 2,655 | |
| Accretion and short-term investment discount | - | (197) | |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (131) | 216 | |
| Inventories | 174 | (97) | |
| Prepaid expenses and other current assets | (169) | (7) | |
| Other assets | 21 | 24 | |
| Accounts payable | 117 | 563 | |
| Accrued liabilities | 192 | (1,547) | |
| Deferred revenue | (775) | 768 | |
| Net cash used in operating activities | (2,346) | (2,802) | |
| Cash flows from investing activities | |||
| Purchase of property and equipment | - | (349) | |
| Net cash used in investing activities | - | (349) | |
| Cash flows from financing activities | |||
| Proceeds from issuance of stock, net of issuance costs | 30 | 56 | |
| Net cash provided by financing activities | 30 | 56 | |
| Net decrease in cash, cash equivalents, and restricted cash | (2,316) | (3,095) | |
| Cash, cash equivalents, and restricted cash at beginning of period | 20,562 | 9,855 | |
| Cash, cash equivalents, and restricted cash at end of period | $18,246 | $6,760 | |
| Supplemental disclosure of cash flow information: | |||
| Purchase of property and equipment included in accounts payable | $ | - | $15 |
| Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of March 31st: | |||
| Cash and cash equivalents | $17,633 | $5,623 | |
| Restricted cash - current | 525 | 525 | |
| Restricted cash | 88 | 612 | |
| Total cash, cash equivalents, and restricted cash | $18,246 | $6,760 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.